| Financial Year |
March 31 2023 |
| Monetary Funds |
261,939,345.60 |
| Held-for-trading Financial Assets |
193,987,726.09 |
| Notes Receivable |
-- |
| Accounts Receivable |
212,574,438.04 |
| Advances to Suppliers |
6,016,409.86 |
| Other Receivables |
4,130,083.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
104,758,324.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,095,484.75 |
| Total Current Assets |
806,570,795.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
146,838,879.11 |
| Under-construction Projects |
73,362,616.39 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
55,231,213.43 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
73,808,938.65 |
| Deferred Income Tax Assets |
8,675,150.53 |
| Other Non-Current Assets |
4,909,864.45 |
| Sub-Total of Non-Current Assets |
369,746,391.78 |
| Total Assets |
1,176,317,187.12 |
| Short-Term Loans |
130,121,305.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,491,881.29 |
| Accounts Payable |
55,089,661.44 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,713,753.15 |
| Taxes Payable |
5,001,435.37 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
286,352.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,834,368.63 |
| Other Current Liabilities |
201,191.70 |
| Sub-Total of Current Liabilities |
203,334,366.86 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,256,885.94 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,851,424.26 |
| Total Liabilities |
214,185,791.12 |
| Paid-In Capital(Or Share Stock) |
130,000,000.00 |
| Capital Surplus |
554,069,569.48 |
| Surplus Reserve |
31,339,879.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
246,375,471.03 |
| Minority Stockholder's Interest |
346,476.49 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
961,784,919.51 |
| Owner's Equity（Stockholder's Equity） |
962,131,396.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,176,317,187.12 |
